JP2010195714A5 - - Google Patents

Download PDF

Info

Publication number
JP2010195714A5
JP2010195714A5 JP2009042671A JP2009042671A JP2010195714A5 JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5 JP 2009042671 A JP2009042671 A JP 2009042671A JP 2009042671 A JP2009042671 A JP 2009042671A JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
substance
derivative
composition according
hyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009042671A
Other languages
Japanese (ja)
Other versions
JP2010195714A (en
JP5560570B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2009042671A priority Critical patent/JP5560570B2/en
Priority claimed from JP2009042671A external-priority patent/JP5560570B2/en
Publication of JP2010195714A publication Critical patent/JP2010195714A/en
Publication of JP2010195714A5 publication Critical patent/JP2010195714A5/ja
Application granted granted Critical
Publication of JP5560570B2 publication Critical patent/JP5560570B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

アミノ酸配列がＨｙｐ−Ｇｌｙで表されるジペプチドまたはその薬理学的に許容される誘導体を含有し、皮下または経皮により投与されることを特徴とする、創傷治療のための医薬組成物。 A pharmaceutical composition for treating wounds, which comprises a dipeptide represented by Hyp-Gly or a pharmacologically acceptable derivative thereof , and is administered subcutaneously or transdermally . 剤形が、クリーム剤、ゲル剤、軟膏剤、液剤、粉剤、塗布剤、乳剤、噴霧剤、滴剤、散剤、貼付剤またはドレッシング剤である、請求項１に記載の医薬組成物。 The pharmaceutical composition according to claim 1 , wherein the dosage form is a cream, gel, ointment, liquid, powder, coating agent, emulsion, spray, drop, powder, patch or dressing. アミノ酸配列がＨｙｐ−Ｇｌｙで表されるジペプチドまたはその薬理学的に許容される誘導体を含有し、剤形が、塗布剤、貼付剤またはドレッシング剤である、創傷治療のための医薬組成物。A pharmaceutical composition for treating wounds, which comprises a dipeptide whose amino acid sequence is represented by Hyp-Gly or a pharmacologically acceptable derivative thereof, and whose dosage form is a coating agent, a patch or a dressing. 前記ペプチドまたはその誘導体の含有量が０．１〜５０重量％である、請求項１〜３のいずれか一項に記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 3, wherein the content of the peptide or a derivative thereof is 0.1 to 50% by weight. 前記ペプチドまたはその誘導体の含有量が０．５〜１０重量％である、請求項１〜３のいずれか一項に記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 3, wherein the content of the peptide or a derivative thereof is 0.5 to 10% by weight. さらに、止血活性物質、成長因子、抗感染物質、鎮痛物質および抗炎症物質からなる群より選択される一種類以上を含む、請求項１〜５のいずれか一項に記載の医薬組成物。 Furthermore, the pharmaceutical composition as described in any one of Claims 1-5 containing 1 or more types selected from the group which consists of a hemostatic active substance, a growth factor, an anti-infective substance, an analgesic substance, and an anti-inflammatory substance.
JP2009042671A 2009-02-25 2009-02-25 Pharmaceutical composition for wound treatment Expired - Fee Related JP5560570B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (en) 2009-02-25 2009-02-25 Pharmaceutical composition for wound treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (en) 2009-02-25 2009-02-25 Pharmaceutical composition for wound treatment

Publications (3)

Publication Number Publication Date
JP2010195714A JP2010195714A (en) 2010-09-09
JP2010195714A5 true JP2010195714A5 (en) 2012-01-05
JP5560570B2 JP5560570B2 (en) 2014-07-30

Family

ID=42820835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009042671A Expired - Fee Related JP5560570B2 (en) 2009-02-25 2009-02-25 Pharmaceutical composition for wound treatment

Country Status (1)

Country Link
JP (1) JP5560570B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5459826B2 (en) * 2009-03-03 2014-04-02 林兼産業株式会社 Elastin production promoter and vascular endothelial cell growth promoter in dermal fibroblasts
JP6709440B2 (en) * 2018-06-08 2020-06-17 学校法人福岡大学 Composition for inhibiting hypertrophic scar formation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257084B1 (en) * 1986-02-28 1990-12-27 Hafslund Nycomed AS Use of a dipeptide with cell growth regulating effect for the preparation of a medicament
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
JP2002255847A (en) * 2001-02-26 2002-09-11 Miyagi Kagaku Kogyo Kk Collagen production promoter, functional food and pharmaceutical preparation
JP2003137807A (en) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk Collagen-producing promoter, cosmetic, food and pharmaceutical containing the same and external preparation for preventing or improving dermatosis
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
JP2005289819A (en) * 2004-03-31 2005-10-20 Nippon Meat Packers Inc Peptide effective in regenerating skin tissue and in improving skin quality and food, medicament, or external preparation containing the peptide
JP4490498B2 (en) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 Disease inhibitor

Similar Documents

Publication Publication Date Title
HRP20170358T1 (en) Inhibitors of histone demethylases
US20160136231A1 (en) Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
JP2008044951A5 (en)
AU2016359706B2 (en) Topical film-forming spray
US20220257642A1 (en) Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
JP2016516808A5 (en)
HRP20220929T3 (en) Inhalation composition containing aclidinium for treatment of asthma
JP2016516023A5 (en)
JP2009102342A5 (en)
JP2009506978A5 (en)
HRP20171048T1 (en) Novel angiotensin type 2 (at2) receptor agonists and uses thereof
RU2007101538A (en) APPLICATION OF PHARMACEUTICAL COMPOSITION CONTAINING CALCITRIOL AND CLOBETASOL PROPIONATE FOR THE TREATMENT OF PSORIASIS
EA201291089A1 (en) METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS INTENDED FOR ORAL ADMINISTRATION, CONTAINING ONE OR MORE ACTIVE INGREDIENTS AND CONTAINING COMPOSITIONS
JP2010536745A5 (en)
JP2023510661A (en) Methods and compositions for producing nitrogen oxides and their use
JP2010514834A5 (en)
JP2006527234A5 (en)
JP2009506002A5 (en)
JP2013542954A5 (en)
JP2016513107A5 (en)
RU2013157398A (en) COMPOSITION
JP2016517882A5 (en)
JP2010195714A5 (en)
AU2015287947B2 (en) Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition
EA201591768A1 (en) DOSED PREPARATIONS AS OPIOID RECEPTOR MODULATORS